NIH Study Reveals Brain Cells Driving Human Speech Activity
BETHESDA, Md., June 20, 2026 Researchers supported by the National Institutes of Health (NIH) have achieved a groundbreaking milestone...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BETHESDA, Md., June 20, 2026 Researchers supported by the National Institutes of Health (NIH) have achieved a groundbreaking milestone...
OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...
LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...
BEIJING, China, June 12, 2026 Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) has announced a significant step forward in its...
NEWPORT BEACH, Calif., June 11, 2026 Wave Neuroscience announced that the U.S. Food and Drug Administration (FDA) has granted...
San Mateo, California & Chicago, Illinois, U.S. | April 15, 2026 Cala Health has announced a major regulatory milestone...
NEW YORK, March 3, 2026 The global Implanted Brain-Computer Interface (BCI) Devices Market is projected to grow at a...
